Brain and Mind Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
J Neuroimmune Pharmacol. 2024 Jun 15;19(1):30. doi: 10.1007/s11481-024-10132-y.
Chronic neuropathic pain precipitates a complex range of affective and behavioural disturbances that differ markedly between individuals. While the reasons for differences in pain-related disability are not well understood, supraspinal neuroimmune interactions are implicated. Minocycline has antidepressant effects in humans and attenuates affective disturbances in rodent models of pain, and acts by reducing neuroinflammation in both the spinal cord and brain. Previous studies, however, tend not to investigate how minocycline modulates individual affective responses to nerve injury, or rely on non-naturalistic behavioural paradigms that fail to capture the complexity of rodent behaviour. We investigated the development and resolution of pain-related affective disturbances in nerve-injured male rats by measuring multiple spontaneous ethological endpoints on a longitudinal naturalistic foraging paradigm, and the effect of chronic oral minocycline administration on these changes. Disrupted foraging behaviours appeared in 22% of nerve-injured rats - termed 'affected' rats - and were present at day 14 but partially resolved by day 21 post-injury. Minocycline completely prevented the emergence of an affected subgroup while only partly attenuating mechanical allodynia, dissociating the relationship between pain and affect. This was associated with a lasting downregulation of ΔFosB expression in ventral hippocampal neurons at day 21 post-injury. Markers of microglia-mediated neuroinflammation were not present by day 21, however proinflammatory microglial polarisation was apparent in the medial prefrontal cortex of affected rats and not in CCI minocycline rats. Individual differences in affective disturbances following nerve injury are therefore temporally related to altered microglial morphology and hippocampal neuronal activation, and are abrogated by minocycline.
慢性神经性疼痛会引发一系列复杂的情感和行为障碍,这些障碍在个体之间有明显的差异。虽然导致疼痛相关残疾差异的原因尚不清楚,但涉及到脊髓上的神经免疫相互作用。米诺环素在人类中具有抗抑郁作用,并减轻疼痛模型中啮齿动物的情感障碍,其作用机制是减少脊髓和大脑中的神经炎症。然而,先前的研究往往没有研究米诺环素如何调节个体对神经损伤的情感反应,或者依赖于不能捕捉到啮齿动物行为复杂性的非自然行为范式。我们通过在纵向自然觅食范式上测量多个自发行为学终点,研究了神经损伤雄性大鼠疼痛相关情感障碍的发展和解决,以及慢性口服米诺环素给药对这些变化的影响。22%的神经损伤大鼠出现了觅食行为障碍,称为“受影响”大鼠,这种障碍在损伤后第 14 天出现,但在第 21 天部分缓解。米诺环素完全阻止了受影响亚组的出现,而只是部分减轻机械性痛觉过敏,从而分离了疼痛和情感之间的关系。这与损伤后第 21 天腹侧海马神经元中 ΔFosB 表达的持久下调有关。然而,在第 21 天,没有观察到小胶质细胞介导的神经炎症标志物,但是在受影响大鼠的内侧前额叶皮质中出现了促炎小胶质细胞极化,而在 CCI 米诺环素大鼠中则没有。因此,神经损伤后情感障碍的个体差异与小胶质细胞形态和海马神经元激活的改变有关,并且可以被米诺环素阻断。